Kirkland & Ellis has advised Olympus Partners and EyeSouth Partners. Sidley Austin has advised Cencora. Cencora Inc. has agreed to purchase the retina-care business of EyeSouth...
Cencora Acquires Retina Business of EyeSouth Partners for $1.1 Billion
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
FFL Partners Invests in Janus RX to Support Behavioral Pharmacy Expansion
Kirkland & Ellis has advised FFL Partners. Bass, Berry & Sims has served as regulatory counsel to FFL Partners. Bradley Arant Boult Cummings has advised Janus...
Curewell Capital Invests in Wilmington PharmaTech
Kirkland & Ellis has advised Curewell Capital, and Potter Anderson has advised Wilmington PharmaTech. Curewell Capital, a Los Angeles-based private equity firm, has made a majority...
Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion
Ropes & Gray has advised Novo Nordisk, and Kirkland & Ellis has advised Akero Therapeutics. Novo Nordisk has entered into a definitive agreement to acquire Akero...
Owens & Minor’s $1.36 Billion Acquisition of Rotech
Kirkland & Ellis is advising KKR on the transaction, and Paul Weiss Rifkind Wharton & Garrison is advising Rotech Healthcare Holdings, Inc. Fried Frank acted as...
Yellow Corp.’s Chapter 11 Bankruptcy
Kirkland & Ellis served as Yellow’s restructuring counsel, Pachulski Stang served as Yellow’s Delaware local counsel, Kasowitz Benson and Torres served as special litigation counsel and...